These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1287729)

  • 1. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease.
    Potter H
    Prog Brain Res; 1992; 94():447-58. PubMed ID: 1287729
    [No Abstract]   [Full Text] [Related]  

  • 2. The involvement of amyloid associated proteins in the formation of beta-protein filaments in Alzheimer's disease.
    Potter H; Ma J; Das S; Kayyali U
    Prog Clin Biol Res; 1994; 390():57-71. PubMed ID: 7724651
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Annu Rev Cell Biol; 1994; 10():373-403. PubMed ID: 7888181
    [No Abstract]   [Full Text] [Related]  

  • 4. Processing and secretion of Alzheimer's disease amyloid precursor protein.
    Kinbara K; Kitagaki H; Kinouchi T; Okano M; Sorimachi H; Ishiura S; Suzuki K
    Tohoku J Exp Med; 1994 Nov; 174(3):209-16. PubMed ID: 7761986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular pathology of amyloid deposition in Alzheimer's disease.
    Martins RN; Robinson PJ; Chleboun JO; Beyreuther K; Masters CL
    Mol Neurobiol; 1991; 5(2-4):389-98. PubMed ID: 1823142
    [No Abstract]   [Full Text] [Related]  

  • 6. The amyloid beta protein precursor mutations linked to familial Alzheimer's disease alter processing in a way that fosters amyloid deposition.
    Younkin SG
    Tohoku J Exp Med; 1994 Nov; 174(3):217-23. PubMed ID: 7761987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.
    Nilsson LN; Bales KR; DiCarlo G; Gordon MN; Morgan D; Paul SM; Potter H
    J Neurosci; 2001 Mar; 21(5):1444-51. PubMed ID: 11222634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease.
    Nilsson LN; Das S; Potter H
    Neurochem Int; 2001; 39(5-6):361-70. PubMed ID: 11578771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of Alzheimer's disease.
    Whitehouse PJ; Landreth G; Younkin S
    Mol Genet Med; 1993; 3():95-137. PubMed ID: 8220165
    [No Abstract]   [Full Text] [Related]  

  • 10. The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease.
    Abraham CR; Potter H
    Ann Med; 1989; 21(2):77-81. PubMed ID: 2669847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.
    Abraham CR; Selkoe DJ; Potter H
    Cell; 1988 Feb; 52(4):487-501. PubMed ID: 3257719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the proteolytic degradation of the beta-protein precursor by proteases purified from Alzheimer's disease brain.
    Abraham CR; Razzaboni BL; Sisodia SS; Koo EH; Price DL; Van Nostrand WE; Papastoitsis G
    Ann N Y Acad Sci; 1991; 640():161-5. PubMed ID: 1776735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor.
    Van Nostrand WE; Wagner SL; Suzuki M; Choi BH; Farrow JS; Geddes JW; Cotman CW; Cunningham DD
    Nature; 1989 Oct; 341(6242):546-9. PubMed ID: 2507928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloidosis in Alzheimer's disease.
    Allsop D; Williams CH
    Biochem Soc Trans; 1994 Feb; 22(1):171-5. PubMed ID: 8206218
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
    Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
    Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
    [No Abstract]   [Full Text] [Related]  

  • 17. The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease.
    Potter H; Nelson RB; Das S; Siman R; Kayyali US; Dressler D
    Ann N Y Acad Sci; 1992 Dec; 674():161-73. PubMed ID: 1288361
    [No Abstract]   [Full Text] [Related]  

  • 18. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.
    Savage MJ; Iqbal M; Loh T; Trusko SP; Scott R; Siman R
    Neuroscience; 1994 Jun; 60(3):607-19. PubMed ID: 7936190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein.
    Petanceska SS; Gandy S
    J Neurochem; 1999 Dec; 73(6):2316-20. PubMed ID: 10582589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease.
    Checler F
    J Neurochem; 1995 Oct; 65(4):1431-44. PubMed ID: 7561836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.